Status:
UNKNOWN
Intervention Study of Drugs in Patients Osteopenia and Osteoporosis
Lead Sponsor:
Chinese PLA General Hospital
Collaborating Sponsors:
Beijing Jishuitan Hospital
Beijing Aerospace General Hospital
Conditions:
Osteoporosis
Osteopenia, Osteoporosis
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This is a 12 months, randomized, multicenter, open-label, parallel-group study in postmenopausal women and male aged 50 years or old with osteoporosis or osteopenia in China to evaluate the efficacy a...
Detailed Description
This is a 12 months,randomized, multicenter, open-label, pragmatic-group study in postmenopausal women and male aged 50 years or old with osteoporosis or osteopenia in China to evaluate the efficacy a...
Eligibility Criteria
Inclusion
- Informed consent obtained before any trial-related activities
- Postmenopausal women and male aged 50 years or old
- Osteoporosis by DXA or fragility fracture history
- Osteopenia with more than one osteoporotic risk factors
Exclusion
- Secondary osteoporosis
- Renal insufficiency (Ccr\< 35ml/min)
- New fractures \< 3 months, prior bilateral hip fractures or surgical replacement.
- Other medication contraindications
- Malignant tumors
- Mobility-impaired individuals
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04719572
Start Date
March 1 2021
End Date
January 1 2023
Last Update
January 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PLA General Hospital
Beijing, Beijing Municipality, China, 100853